Institution · Abbott Fund
Most cited papers from Abbott Fund
What are the most cited papers from Abbott Fund?
The most cited paper from Abbott Fund is "Core outcome domains for chronic pain clinical trials: IMMPACT recommendations" (Dennis C. Turk et al., 2003), with 3,518 citations. Next come "An inhibitor of Bcl-2 family proteins induces regression of solid tumours" (3,430) and "Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM Trial" (2,263).
Showing 50 of 60 papers. Every paper with more than 552 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Core outcome domains for chronic pain clinical trials: IMMPACT recommendations Dennis C. Turk et al. · Pain | 22 Sep 2003 | 3,518 |
| 2 | An inhibitor of Bcl-2 family proteins induces regression of solid tumours Tilman Oltersdorf et al. · Nature | 15 May 2005 | 3,430 |
| 3 | Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM Trial Jean–Frédéric Colombel, William J. Sandborn, Paul J. Rutgeerts et al. · Gastroenterology | 30 Nov 2006 | 2,263 |
| 4 | Limit of blank, limit of detection and limit of quantitation. David Armbruster, Terry Pry · PubMed | Aug 2008 | 2,149 |
| 5 | Concordance of the Toxicity of Pharmaceuticals in Humans and in Animals Harry M. Olson, Graham R. Betton, Denise E. Robinson et al. · Regulatory Toxicology and Pharmacology | Aug 2000 | 2,056 |
| 6 | ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor Christin Tse, Alexander R. Shoemaker, Jessica Adickes et al. · Cancer Research | May 2008 | 1,999 |
| 7 | Prospective Study of C-Reactive Protein and the Risk of Future Cardiovascular Events Among Apparently Healthy Women Paul M. Ridker, Julie E. Buring, Jessie Shih et al. · Circulation | 25 Aug 1998 | 1,654 |
| 8 | Tumor necrosis factor antagonist mechanisms of action: A comprehensive review Daniel E. Tracey, Lars Klareskog, Eric H. Sasso et al. · Pharmacology & Therapeutics | 14 Nov 2007 | 1,636 |
| 9 | Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease Adeera Levin, George L. Bakris, Mark E. Molitch et al. · Kidney International | 8 Nov 2006 | 1,522 |
| 10 | Viruses and interferon: a fight for supremacy Michael G. Katze, Yupeng He, Michael Gale · Nature reviews. Immunology | Sep 2002 | 1,429 |
| 11 | Impact of high-throughput screening in biomedical research Ricardo Macarrón, Martyn N. Banks, Dejan Bojanic et al. · Nature Reviews Drug Discovery | Mar 2011 | 1,406 |
| 12 | Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource Donald B. Smith, Jens Bukh, Carla Kuiken et al. · Hepatology | 11 Oct 2013 | 1,365 |
| 13 | Polypharmacy in elderly patients Emily R. Hajjar, Angela C. Cafiero, Joseph T. Hanlon · The American journal of geriatric pharmacotherapy | Dec 2007 | 1,288 |
| 14 | Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis William J. Sandborn, Gert Van Assche, Walter Reinisch et al. · Gastroenterology | 5 Nov 2011 | 1,274 |
| 15 | National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers Catharine M. Sturgeon et al. · Clinical Chemistry | 28 Nov 2008 | 1,141 |
| 16 | Improving Marginal Likelihood Estimation for Bayesian Phylogenetic Model Selection Wangang Xie, Paul O. Lewis, Yu Fan et al. · Systematic Biology | 27 Dec 2010 | 1,121 |
| 17 | Promoting apoptosis as a strategy for cancer drug discovery Stephen W. Fesik · Nature reviews. Cancer | 20 Oct 2005 | 1,104 |
| 18 | Sedative, Amnestic, and Analgesic Properties of Small-Dose Dexmedetomidine Infusions Judith Hall, Toni D. Uhrich, Jill A. Barney et al. · Anesthesia & Analgesia | Mar 2000 | 1,083 |
| 19 | Adalimumab for maintenance treatment of Crohn’s disease: results of the CLASSIC II trial William J. Sandborn, Stephen B. Hanauer, Paul Rutgeerts et al. · Gut | 13 Feb 2007 | 1,043 |
| 20 | A General and Fast Scoring Function for Protein−Ligand Interactions: A Simplified Potential Approach Ingo Muegge, Yvonne Connolly Martin · Journal of Medicinal Chemistry | 24 Feb 1999 | 1,015 |
| 21 | Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Jennifer S. Pollock, Ulrich Förstermann, Jane A. Mitchell et al. · Proceedings of the National Academy of Sciences | Dec 1991 | 985 |
| 22 | Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects W. P. T. James, Ian Douglas Caterson, Walmir Ferreira Coutinho et al. · New England Journal of Medicine | Sep 2010 | 947 |
| 23 | Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review Todd Tarquin Brown, Roula B. Qaqish · AIDS | 3 Nov 2006 | 933 |
| 24 | Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome Barbara L. Cool, Bradley A. Zinker, William J.H. Chiou et al. · Cell Metabolism | Jun 2006 | 930 |
| 25 | The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models Leming M. Shi et al. · Nature Biotechnology | 30 Jul 2010 | 922 |
| 26 | Modular Organization of Genes Required for Complex Polyketide Biosynthesis Stefano Donadio, Michael J. Staver, James B. McAlpine et al. · Science | 3 May 1991 | 914 |
| 27 | Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: Results of a double‐blind, randomized, placebo‐controlled trial Philip J. Mease, Dafna D. Gladman, Christopher T. Ritchlin et al. · Arthritis & Rheumatism | 30 Sep 2005 | 912 |
| 28 | Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial Alan Menter, Stephen Keith Tyring, Kenneth B. Gordon et al. · Journal of the American Academy of Dermatology | 3 Dec 2007 | 892 |
| 29 | Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity Wyndham Hopkins Wilson, Owen A. O’Connor, Myron Stefan Czuczman et al. · The Lancet Oncology | 20 Nov 2010 | 873 |
| 30 | ICTV Virus Taxonomy Profile: Flaviviridae Peter Simmonds, Paul Becher, Jens Bukh et al. · Journal of General Virology | 2017 | 866 |
| 31 | Tumour-initiating cells: challenges and opportunities for anticancer drug discovery Bin‐Bing S. Zhou, Haiying Zhang, Marc Isaac Damelin et al. · Nature Reviews Drug Discovery | Oct 2009 | 848 |
| 32 | Do Structurally Similar Molecules Have Similar Biological Activity? Yvonne Connolly Martin, James L. Kofron, Linda M. Traphagen · Journal of Medicinal Chemistry | 13 Aug 2002 | 840 |
| 33 | Isoforms of nitric oxide synthase Characterization and purification from different cell types Ulrich Förstermann, Harald H.H.W. Schmidt, Jennifer S. Pollock et al. · Biochemical Pharmacology | Oct 1991 | 825 |
| 34 | Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7 Ingrid E. Wertz et al. · Nature | 2 Mar 2011 | 823 |
| 35 | Bcl-xL forms an ion channel in synthetic lipid membranes Andy J. Minn, Patricio Vélez, Sharon L. Schendel et al. · Nature | 1997 | 819 |
| 36 | A case for including spirituality in quality of life measurement in oncology Marianne J. Brady, Amy H. Peterman, George A. Fitchett et al. · Psycho-Oncology | Sep 1999 | 803 |
| 37 | The Efficacy of Terazosin, Finasteride, or Both in Benign Prostatic Hyperplasia Herbert Lepor, William O. Williford, Michael J. Barry et al. · New England Journal of Medicine | 22 Aug 1996 | 801 |
| 38 | ABT-888, an Orally Active Poly(ADP-Ribose) Polymerase Inhibitor that Potentiates DNA-Damaging Agents in Preclinical Tumor Models Cherrie K. Donawho et al. · Clinical Cancer Research | May 2007 | 775 |
| 39 | Ordered accumulation of mutations in HIV protease confers resistance to ritonavir Akhteruzzaman Molla, Marina Korneyeva, Qing Chun Gao et al. · Nature Medicine | Jul 1996 | 771 |
| 40 | Use of In Vitro and In Vivo Data to Estimate the Likelihood of Metabolic Pharmacokinetic Interactions Richard Bertz, G. Richard Granneman · Clinical Pharmacokinetics | Mar 1997 | 754 |
| 41 | Structural biology of the Bcl-2 family of proteins Andrew M. Petros, Edward T. Olejniczak, Stephen W. Fesik · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research | 4 Dec 2003 | 737 |
| 42 | Sarcopenia Definition: The Position Statements of the Sarcopenia Definition and Outcomes Consortium Shalender Bhasin et al. · Journal of the American Geriatrics Society | 9 Mar 2020 | 718 |
| 43 | Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: A composite of redistribution and proliferation Nadine G. Pakker, Daan W. Notermans, Rob J. de Boer et al. · Nature Medicine | Feb 1998 | 715 |
| 44 | Class-Sparing Regimens for Initial Treatment of HIV-1 Infection Sharon A. Riddler, Richard Haubrich, Albert Gregory DiRienzo et al. · New England Journal of Medicine | 14 May 2008 | 681 |
| 45 | The odyssey of marine pharmaceuticals: a current pipeline perspective Alejandro M. S. Mayer, Keith B. Glaser, Carmen Cuevas et al. · Trends in Pharmacological Sciences | 6 Apr 2010 | 669 |
| 46 | Mycolactone: A Polyketide Toxin from Mycobacterium ulcerans Required for Virulence Kathleen M. George, Delphi Chatterjee, Geewananda P. Gunawardana et al. · Science | 5 Feb 1999 | 663 |
| 47 | Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy SARAH ELLEN PALMER, Frank M. Maldarelli, Ann Wiegand et al. · Proceedings of the National Academy of Sciences | 10 Mar 2008 | 656 |
| 48 | Use of Structure−Activity Data To Compare Structure-Based Clustering Methods and Descriptors for Use in Compound Selection Robert D. Brown, Yvonne Connolly Martin · Journal of Chemical Information and Computer Sciences | 1996 | 634 |
| 49 | Kinetics of Response in Lymphoid Tissues to Antiretroviral Therapy of HIV-1 Infection Winston P. Cavert, Daan W. Notermans, Katherine Staskus et al. · Science | 9 May 1997 | 633 |
| 50 | Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2 Joseph E. Ebinger, Justyna Fert‐Bober, Ignat Printsev et al. · Nature Medicine | Apr 2021 | 621 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.